Products & Services · Total revenues
Product sales — Total revenues
Amgen Product sales — Total revenues decreased by 4.6% to $8.22B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.8%, from $8.15B to $8.22B. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2019
Last reportedQ1 2026Apr 30, 2026
Rolls up toTotal Revenue
How to read this metric
An increase indicates growing market adoption or successful pricing strategies for the segment's products, while a decrease suggests potential market saturation, competitive pressure, or product lifecycle decline.
Detailed definition
This metric represents the total gross revenue generated from the sale of therapeutic products within a specific busines...
Peer comparison
Comparable to 'Net Product Sales' or 'Segment Revenue' reported by other large-cap biotechnology and pharmaceutical firms.
Metric ID:
amgn_segment_product_sales_total_revenuesHistorical Data
40 periods
| Q2 '21 | Q2 '21 | Q3 '21 | Q3 '21 | Q4 '21 | Q4 '21 | Q1 '22 | Q1 '22 | Q2 '22 | Q2 '22 | Q3 '22 | Q3 '22 | Q4 '22 | Q4 '22 | Q1 '23 | Q1 '23 | Q2 '23 | Q2 '23 | Q3 '23 | Q3 '23 | Q4 '23 | Q4 '23 | Q1 '24 | Q1 '24 | Q2 '24 | Q2 '24 | Q3 '24 | Q3 '24 | Q4 '24 | Q4 '24 | Q1 '25 | Q1 '25 | Q2 '25 | Q2 '25 | Q3 '25 | Q3 '25 | Q4 '25 | Q4 '25 | Q1 '26 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.53B | $6.11B | $6.71B | $6.32B | $6.85B | $6.27B | $6.24B | $5.73B | $6.59B | $6.28B | $6.65B | $6.24B | $6.84B | $6.55B | $6.11B | $5.85B | $6.99B | $6.68B | $6.9B | $6.55B | $8.2B | $7.83B | $7.45B | $7.12B | $8.39B | $8.04B | $8.5B | $8.15B | $9.09B | $8.72B | $8.15B | $7.87B | $9.18B | $8.77B | $9.56B | $9.14B | $9.87B | $9.37B | $8.62B | $8.22B |
| QoQ Change | — | -6.3% | +9.7% | -5.8% | +8.3% | -8.4% | -0.5% | -8.1% | +15.1% | -4.7% | +5.9% | -6.2% | +9.7% | -4.2% | -6.8% | -4.2% | +19.5% | -4.3% | +3.3% | -5.1% | +25.2% | -4.4% | -4.9% | -4.4% | +17.8% | -4.1% | +5.7% | -4.1% | +11.5% | -4.1% | -6.5% | -3.4% | +16.6% | -4.4% | +9.0% | -4.4% | +8.0% | -5.1% | -8.0% | -4.6% |
| YoY Change | — | — | — | — | — | — | — | — | +1.0% | -3.8% | -0.8% | -7.0% | -0.1% | -4.3% | -2.1% | -6.3% | +5.9% | +1.3% | +3.8% | -1.6% | +19.8% | +14.5% | +22.0% | +16.6% | +20.1% | +15.1% | +23.2% | +18.1% | +10.9% | +6.3% | +9.4% | +5.7% | +9.4% | +4.6% | +12.4% | +7.5% | +8.6% | +3.1% | +5.8% | +0.8% |
Range$5.73B – $9.87B
CAGR+2.4%
Avg YoY Growth+6.9%
Median YoY Growth+5.9%
Current Streak3 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Amgen's product sales — total revenues?
- Amgen (AMGN) reported product sales — total revenues of $8.22B in Q1 2026.
- How has Amgen's product sales — total revenues changed year-over-year?
- Amgen's product sales — total revenues increased by 0.8% year-over-year, from $8.15B to $8.22B.
- What does product sales — total revenues mean?
- The total amount of money generated from selling products within this specific business segment.